10
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      International Journal of Nanomedicine (submit here)

      This international, peer-reviewed Open Access journal by Dove Medical Press focuses on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. Sign up for email alerts here.

      105,621 Monthly downloads/views I 7.033 Impact Factor I 10.9 CiteScore I 1.22 Source Normalized Impact per Paper (SNIP) I 1.032 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      131I-labeled polyethylenimine-entrapped gold nanoparticles for targeted tumor SPECT/CT imaging and radionuclide therapy

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose: Polyethylenimine (PEI) has been widely used as a versatile template to develop multifunctional nanosystems for disease diagnosis and treatment. In this study, we manufactured iodine-131 ( 131I)-labeled PEI-entrapped gold nanoparticles (Au PENPs) as a novel nanoprobe for single-photon emission computed tomography/computed tomography (SPECT/CT) imaging and radionuclide therapy.

          Materials and methods: PEI was PEGylated and sequentially conjugated with Buthus martensii Karsch chlorotoxin (BmK CT, a tumor-specific ligand which can selectively bind to MMP2), 3-(4′-hydroxyphenyl)propionic acid-OSu (HPAO), and fluorescein isothiocyanate to form the multifunctional PEI template for entrapment of Au NPs. Then, the PEI surface was radiolabeled with 131I via HPAO to produce the novel nanoprobe (BmK CT-Au PENPs- 131I).

          Results: The synthesized multifunctional Au PENPs before and after 131I radiolabeling were well-characterized as follows: structure, X-ray attenuation coefficient, colloid stability, cytocompatibility, and radiochemical stability in vitro. Furthermore, BmK CT-Au PENPs- 131I were suitable for targeted SPECT/CT imaging and radionuclide therapy of tumor cells in vitro and in a xenograft tumor model in vivo.

          Conclusion: The developed multifunctional Au PENPs are a promising theranostic platform for targeted imaging and treatment of different MMP2-overexpressing tumors.

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.

          Cancer is a leading cause of death worldwide. Currently available therapies are inadequate and spur demand for improved technologies. Rapid growth in nanotechnology towards the development of nanomedicine products holds great promise to improve therapeutic strategies against cancer. Nanomedicine products represent an opportunity to achieve sophisticated targeting strategies and multi-functionality. They can improve the pharmacokinetic and pharmacodynamic profiles of conventional therapeutics and may thus optimize the efficacy of existing anti-cancer compounds. In this review, we discuss state-of-the-art nanoparticles and targeted systems that have been investigated in clinical studies. We emphasize the challenges faced in using nanomedicine products and translating them from a preclinical level to the clinical setting. Additionally, we cover aspects of nanocarrier engineering that may open up new opportunities for nanomedicine products in the clinic.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Targeted gold nanoparticles enable molecular CT imaging of cancer.

            X-ray based computed tomography (CT) is among the most convenient imaging/diagnostic tools in hospitals today in terms of availability, efficiency, and cost. However, in contrast to magnetic resonance imaging (MRI) and various nuclear medicine imaging modalities, CT is not considered a molecular imaging modality since targeted and molecularly specific contrast agents have not yet been developed. Here we describe a targeted molecular imaging platform that enables, for the first time, cancer detection at the cellular and molecular level with standard clinical CT. The method is based on gold nanoprobes that selectively and sensitively target tumor selective antigens while inducing distinct contrast in CT imaging (increased X-ray attenuation). We present an in vitro proof of principle demonstration for head and neck cancer, showing that the attenuation coefficient for the molecularly targeted cells is over 5 times higher than for identical but untargeted cancer cells or for normal cells. We expect this novel imaging tool to lead to significant improvements in cancer therapy due to earlier detection, accurate staging, and microtumor identification.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Current trends in using polymer coated gold nanoparticles for cancer therapy.

              The interest in using the polymer-coated gold nanoparticles (P-AuNPs) for various biomedical applications, including the delivery of chemotherapeutic in cancer has been increased in the recent years. Various biocompatible polymers, including poly(ethylene glycol), heparin, hyaluronic acid, chitosan, polystyrene sulfonate, polyethyleneimine and xanthan gum are being used for the surface decoration of AuNPs for various purposes such as to improve the stability of the NPs and the payloads, impart biocompatibility, promote long systemic circulation followed by cellular uptake to utilize the AuNPs as drug/nucleic acid delivery system for cancer therapy. This review is an attempt to elucidate various synthesis strategies explored so far, including direct synthesis, "grafting in" and "grafting from" for the preparation of the P-AuNPs. Various therapeutic applications of the P-AuNPs for cancer treatment have been illustrated.
                Bookmark

                Author and article information

                Journal
                Int J Nanomedicine
                Int J Nanomedicine
                IJN
                intjnano
                International Journal of Nanomedicine
                Dove
                1176-9114
                1178-2013
                11 June 2019
                2019
                : 14
                : 4367-4381
                Affiliations
                [1 ]Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai 200080, People’s Republic of China
                [2 ]State Key Laboratory of Material-Oriented Chemical Engineering, School of Pharmaceutical Sciences, Nanjing Tech University , Nanjing 211816, People’s Republic of China
                Author notes
                Correspondence: He HuangState Key Laboratory of Material-Oriented Chemical Engineering, School of Pharmaceutical Sciences, Nanjing Tech University , Nanjing211816, People’s Republic of ChinaTel +86 255 813 9942Fax +86 255 813 9942Email huangh@ 123456njtech.edu.cn
                Jinhua ZhaoDepartment of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai200080, People’s Republic of ChinaTel +86 213 779 8352Fax +86 213 779 8352Email zhaojinhua1963@ 123456126.com
                [*]

                These authors contributed equally to this work

                Article
                203259
                10.2147/IJN.S203259
                6580422
                0636e4f3-4a23-4185-9798-5ff3a2ad2c76
                © 2019 Sun et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 01 February 2019
                : 14 April 2019
                Page count
                Figures: 7, Tables: 1, References: 46, Pages: 15
                Categories
                Original Research

                Molecular medicine
                polyethylenimine,bmk ct,gold nanoparticles,spect/ct imaging,radionuclide therapy

                Comments

                Comment on this article